One in Five Cannabis-Related ER Visits Among Young People Involved Fainting
Among nearly 25,000 cannabis-associated ER visits by 15-24 year olds, 21.7% involved syncope (fainting), and the prevalence of syncope was 8.6 times higher among cannabis users than non-users.
Quick Facts
What This Study Found
Analyzing NEISS data from 2019-2022, researchers found that among 24,922 cannabis-associated injuries in young people aged 15-24, 5,400 (21.7%) also involved syncope. The prevalence of syncope among cannabis users was 8.6 times higher than among non-users (PR=8.6, 95% CI: 7.1-10.2). Most injuries were to the head and neck, with falls being the most common mechanism, suggesting syncope leads to fall-related injuries.
Key Numbers
24,922 cannabis-associated injuries (ages 15-24); 5,400 with syncope (21.7%); syncope prevalence ratio 8.6x vs non-cannabis users (95% CI: 7.1-10.2); most injuries to head/neck; falls most common mechanism
How They Did This
Cross-sectional study using the National Electronic Injury Surveillance System (2019-2022). Identified cannabis-associated injuries among 15-24 year olds presenting to emergency departments and screened for concurrent syncope. Calculated prevalence ratios comparing syncopal rates between cannabis users and non-users.
Why This Research Matters
Cannabis-related syncope is underrecognized as a cause of injury in young people. The 8.6-fold higher prevalence suggests a strong association that may be clinically significant, particularly as cannabis potency and use increase.
The Bigger Picture
Syncope after cannabis use is likely related to orthostatic hypotension (blood pressure drop on standing), a known cardiovascular effect of THC. As cannabis products become more potent, the incidence and severity of syncope-related injuries may increase.
What This Study Doesn't Tell Us
NEISS captures injuries leading to ER visits, not all cannabis-related syncope events. Cannot determine causation. Cannabis association based on screening, not confirmed as the cause of syncope. Cannot assess THC dose, product type, or timing relative to use. No information on underlying cardiovascular conditions.
Questions This Raises
- ?Is syncope risk dose-dependent with THC potency?
- ?Should cannabis users be counseled about orthostatic precautions?
Trust & Context
- Key Stat:
- Evidence Grade:
- Moderate: national surveillance data with large sample, but cross-sectional design and cannot confirm cannabis as the cause of syncope.
- Study Age:
- 2025 publication using 2019-2022 data
- Original Title:
- Syncope among adolescents and young adults seeking treatment for cannabis-related injuries.
- Published In:
- The American journal of emergency medicine, 92, 109-113 (2025)
- Authors:
- Hammig, Bart(2), Bordelon, Abigail
- Database ID:
- RTHC-06622
Evidence Hierarchy
A snapshot of a population at one point in time.
What do these levels mean? →Read More on RethinkTHC
- cannabis-cardiovascular-heart-risk-stroke
- cannabis-heart-cardiovascular-risk
- coughing-up-stuff-after-quitting-weed
- lung-recovery-after-quitting-smoking-weed
- lung-recovery-quitting-weed
- quitting-weed-female-hormones
- quitting-weed-weight-gain-loss-diet-appetite
- sex-after-quitting-weed
- weed-DUI-driving-impaired-cannabis-laws
- weed-acne-skin
- weed-fertility-sperm
- weed-gut-digestion-problems
- weed-heart-health
- weed-testosterone-levels
Cite This Study
https://rethinkthc.com/research/RTHC-06622APA
Hammig, Bart; Bordelon, Abigail. (2025). Syncope among adolescents and young adults seeking treatment for cannabis-related injuries.. The American journal of emergency medicine, 92, 109-113. https://doi.org/10.1016/j.ajem.2025.03.003
MLA
Hammig, Bart, et al. "Syncope among adolescents and young adults seeking treatment for cannabis-related injuries.." The American journal of emergency medicine, 2025. https://doi.org/10.1016/j.ajem.2025.03.003
RethinkTHC
RethinkTHC Research Database. "Syncope among adolescents and young adults seeking treatment..." RTHC-06622. Retrieved from https://rethinkthc.com/research/hammig-2025-syncope-among-adolescents-and
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.